Bill

Bill > HB1230


MD HB1230

MD HB1230
Public Health - Tianeptine Consumer Protection Act


summary

Introduced
02/08/2024
In Committee
04/01/2024
Crossed Over
03/13/2024
Passed
04/05/2024
Dead
Signed/Enacted/Adopted
04/25/2024

Introduced Session

2024 Regular Session

Bill Summary

Prohibiting a retailer from distributing, selling, exposing for sale, or advertising for sale a tianeptine product to an individual; and establishing a penalty for a retailer who violates the Act of a fine of up to $5,000 or imprisonment for up to 90 days or both.

AI Summary

This bill, known as the Public Health - Tianeptine Consumer Protection Act, prohibits retailers from distributing, selling, exposing for sale, or advertising for sale any tianeptine product to individuals. Tianeptine is a substance that can be used as a recreational drug and may pose health risks. The bill establishes a penalty for retailers who violate the act, including a fine of up to $5,000 or imprisonment for up to 90 days, or both. Additionally, retailers who violate the act may be liable for civil damages sustained by the individual resulting from the violation. The bill aims to protect consumers, particularly minors, from the potential harms associated with tianeptine products.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (23)

Last Action

Approved by the Governor - Chapter 249 (on 04/25/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...